Analyst Ratings For Allogene Therapeutics
During the last three months, 7 analysts shared their evaluations of Allogene Therapeutics (NASDAQ:ALLO), revealing diverse outlooks from…
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Shares of James Hardie Industries plc (NYSE:JHX) fell sharply during Tuesday’s session after the company reported worse-than-expected quarterly…
Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Larimar Therapeutics, Inc.. (NASDAQ:LRMR) rose sharply in today’s pre-market trading after the company announced that the…
Breaking Down Allogene Therapeutics: 5 Analysts Share Their Views
Throughout the last three months, 5 analysts have evaluated Allogene Therapeutics (NASDAQ:ALLO), offering a diverse set of opinions…
Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) rose sharply in today’s pre-market trading after the company reported better-than-expected first-quarter…
DLocal, Allogene Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 20 points on Wednesday.…
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Monogram Orthopaedics (NASDAQ:MGRM) stock increased by 19.1% to $2.31 during Monday’s pre-market session. The company’s market cap…
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
Investing in the technologies of tomorrow can be a lucrative investment strategy. If investors can discern trends as…
Allogene Therapeutics To Restate Previously Filed Financial Statements Related To The December 2020 Formation Of The Allogene Overland Biopharm Joint Venture In Asia; No Impact On Cash, Cash Equivalents And Marketable Investments, Cash Runway Or Busine…
No Impact on Cash, Cash Equivalents and Marketable Investments, Cash Runway or Business Operations Company Targeting On or Before March 14, 2024 to File Amended Financial Statements and Report Fourth Quarter and
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Nasdaq Composite trading almost flat on Monday.
Shares of CymaBay Therapeutics, Inc. (NASDAQ: CBAY) rose sharply in today’s pre-market trading.